Therapeutic Benefits of a Motor Imaging Protocol Following Anterior Cruciate Ligament Reconstruction Surgery

NCT ID: NCT07210489

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-31

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare changes in lower limb symmetry during functional and strength tests, before and after the motor imagery program, in patients who received the 3-week motor imagery program starting 3 months post-surgery versus patients who did not receive the motor imagery program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, comparative, randomized, controlled, single-blind (patient), single-center study evaluating the effects of a motor imagery program in parallel with rehabilitation sessions in patients who have had an anterior cruciate ligament rupture.

The study population is composed of adult patients who underwent reconstructive surgery after anterior cruciate ligament rupture, followed up at the Clinique de la Sauvegarde in Lyon for post-operative functional and strength testing of the anterior cruciate ligament.

Patients included in the study will be randomized into two study arms (experimental arm and control arm).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anterior Cruciate Ligament Tear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective, comparative, randomized, controlled, single-blind (patient), single-center study
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
single-blind (patient)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Motor imagery program

Patients will receive rehabilitation sessions from a physical therapist in accordance with standard practice and will be asked to complete a 3-week motor imagery program starting 3 months after anterior cruciate ligament surgery.

Group Type EXPERIMENTAL

Reconstructive surgery after anterior cruciate ligament rupture

Intervention Type PROCEDURE

surgical technique for repairing the cruciate ligament

sessions from a physical therapist

Intervention Type OTHER

sessions from a physical therapist in accordance with standard practice

Cognitive (non-motor) task program

Patients will receive rehabilitation sessions from a physical therapist in accordance with standard practice and will be asked to complete a 3-week cognitive (non-motor) task program starting 3 months after anterior cruciate ligament surgery.

Group Type ACTIVE_COMPARATOR

Reconstructive surgery after anterior cruciate ligament rupture

Intervention Type PROCEDURE

surgical technique for repairing the cruciate ligament

sessions from a physical therapist

Intervention Type OTHER

sessions from a physical therapist in accordance with standard practice

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reconstructive surgery after anterior cruciate ligament rupture

surgical technique for repairing the cruciate ligament

Intervention Type PROCEDURE

sessions from a physical therapist

sessions from a physical therapist in accordance with standard practice

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 to 45;
* Individuals who have undergone anterior cruciate ligament reconstruction for the first time on the operated leg;
* All types of surgery (harvesting of the new gracilis or patellar tendon) within 3 months prior to inclusion;
* Patients able to understand and read French;
* Affiliation with a social insurance plan;
* Signed informed consent.

Exclusion Criteria

* Recurrence or rupture of the contralateral anterior cruciate ligament;
* Osteotomy;
* Cognitive disorders observed by the investigator;
* Vestibular disorders known to the patient or observed by the investigator;
* Post-surgical complications (infection, early graft rupture);
* Patient participating in another interventional clinical trial, or in a period of exclusion from another interventional study;
* Patient under guardianship or conservatorship;
* Pregnant or breastfeeding women.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Euraxi Pharma

INDUSTRY

Sponsor Role collaborator

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique de la Sauvegarde

Lyon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Benoit PAIROT DE FONTENAY

Role: CONTACT

601740875 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Benoit PAIROT DE FONTENAY

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A01415-44

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.